| |
|
|
|
AC Immune S.A.  
|
|
5.49 -0.05 (-0.01%) |
12-01 16:00 |
|
Open: |
5.61 |
Pre close: |
5.54 |
Target:
|
6.80
|
|
High: |
5.66 |
Low: |
5.45 |
Resistance:
|
5.82
6.80
|
|
Volume: |
109,282 |
Market Cap: |
394M |
Support:
|
4.95
4.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.41
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
5.23 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
6.26  |
Stochastic Oscillator |
%K(14,3):
|
79.83 |
|
MA(250): |
7.07 |
%D(3): |
71.31 |
|
Average Volume(K) |
3-Month: |
41235
|
52-Week |
High:
|
13.00 |
|
10-Days: |
14182 |
Low: |
4.07 |
|
RSI |
RSI(14):
|
55.83 |
Change(%): |
-29.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-23.5 |
Shares Out. (M) |
71.74 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-13.3 |
Shares Float (M) |
30.44 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.99 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
-96.6 |
% Held by Institutions |
26.77 |
|
Forward EPS |
-0.837 |
Gross Profit (p.s.) |
0.845 |
Shares Short (K) |
1870 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.98 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.84 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
